Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)
Product details
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
First published in 1984, this book examines corporate crime in the pharmaceutical industry and is based on extensive research, including interviews with 131 senior executives of international pharmaceutical companies. It covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs.
Preface 1. Introduction: an industry case study of corporate crime 2. Bribery 3. Safety testing of drugs: from negligence to fraud 4. Unsafe manufacturing practices 5. Antitrust 6. The corporation as pusher 7. Drug companies and the Third World 8. Fiddling 9. Strategies for controlling corporate crime; Appendix: Getting interviews with corporate executives; Notes; Bibliography; Index